Justin Hoffman

Validation of a Clinical Score for Assessing the Risk of Resistant Pathogens in Patients With Pneumonia Presenting to the Emergency Department

Andrew F. Shorr, Marya D. Zilberberg, Richard M. Reichley et al. · Clinical Infectious Diseases · 2011 · 159 citations

Veterinary Medicine, Emergency Medicine, Infectious Diseases +15

<i>Alternaria alternata</i>serine proteases induce lung inflammation and airway epithelial cell activation via PAR₂

Scott Boitano, Andrea N. Flynn, Cara L. Sherwood et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2011 · 110 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

Readmission Following Hospitalization for Pneumonia: The Impact of Pneumonia Type and Its Implication for Hospitals

Andrew F. Shorr, Marya D. Zilberberg, Richard M. Reichley et al. · Clinical Infectious Diseases · 2013 · 59 citations

Medicine, Internal Medicine, Antimicrobial Stewardship +16

The novel <scp>PAR</scp>2 ligand <scp>C</scp>391 blocks multiple <scp>PAR</scp>2 signalling pathways <i>in vitro</i> and <i>in vivo</i>

Scott Boitano, Justin Hoffman, Andrea N. Flynn et al. · British Journal of Pharmacology · 2015 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

The Protease-activated Receptor-2-specific Agonists 2-Aminothiazol-4-yl-LIGRL-NH2 and 6-Aminonicotinyl-LIGRL-NH2 Stimulate Multiple Signaling Pathways to Induce Physiological Responses in Vitro and in Vivo

Andrea N. Flynn, Dipti V. Tillu, Marina N. Asiedu et al. · Journal of Biological Chemistry · 2011 · 30 citations · Full text

Life Sciences, Biochemistry, Pharmacology +7